Siemens AG has agreed to acquire Dotmatics for $5.1 billion as part of a push to provide more artificial intelligence software to life sciences companies.

Germany group Siemens said on Wednesday it is buying Dotmatics, a US software company, for $5.1 billion to leverage its use of artificial intelligence to make drug discoveries.

Siemens AG—and that’s Siemens Siemens, not Siemens Healthineers—is expanding its industrial software business further into the life sciences, with a $5.1 billion plan to acquire digital R | The German conglomerate said the deal would not only add to its work in artificial intelligence and digital twins,